Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Senseonics Holdings (NY: SENS )

0.4767 +0.0077 (+1.64%)
Streaming Delayed Price Updated: 11:16 AM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Senseonics Holdings

< Previous 1 2 3 4 5 6 Next >
The Fundamentals of Senseonics Make No Sense
Some investors probably got rich buying SENS stock when it was cheap and selling it when it skyrocketed. Good for them, but skip it now. 
Via InvestorPlace
SENS Stock: 2 Big Reasons Senseonics Is Squeezing Higher
Today, two key catalysts are driving interest once again in Senseonics and SENS stock as retail investors focus on institutional buying. 
Via InvestorPlace
Senseonics Could Go Higher, Especially if It Nabs FDA Approval
Senseonics looks interesting here, especially with possible FDA approval. SENS stock is worth 24% more at $4, or even $6-plus once its CGM rolls out. 
Via InvestorPlace
Exposures Product Safety
Senseonics Shares Drop On Posting Wider Q2 Loss; Backs FY21 Revenue Outlook
Senseonics Holdings Inc (NYSE: SENS) posted a second-quarter 2021 loss of $(180.3) million, seeing its bottom line plummet from a loss of just $(7.5) million last year... 
Via Benzinga
28 Stocks Moving in Tuesday's Pre-Market Session
Gainers Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares rose 38.6% to $66.88 in pre-market trading after the company reported better-than-expected Q2 earnings and also... 
Via Benzinga
85 Biggest Movers From Yesterday
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX... 
Via Benzinga
54 Stocks Moving In Tuesday's Mid-Day Session
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy... 
Via Benzinga
Senseonics Financials Don’t Support Its Billion-Dollar-Plus Market Cap
Senseonics' revolutionary Eversense glucose monitor may be redefining diabetes treatment, but its current contribution doesn't justify SENS stock rich valuation. 
Via InvestorPlace
Senseonics Is a Solid Recovery Play Poised to Unlock its Potential
SENS stock has rewarded patient investors well. However, this is only the beginning for the company as Eversense remains a gamechanger. 
Via InvestorPlace
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •... 
Via Benzinga
Analyzing Senseonics Holdings's Unusual Options Activity
Shares of Senseonics Holdings (AMEX:SENS) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved down to $2.98. Sentiment:... 
Via Benzinga
Senseonics Stock Might Actually Be Held Back By Its Meme Status
Senseonics may be worth the wait, but SENS stock is largely in the hands of retail investors who are looking to profit from a short squeeze. 
Via InvestorPlace
Analyzing Senseonics Holdings's Unusual Options Activity
Shares of Senseonics Holdings (AMEX:SENS) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $3.02. Sentiment: BEARISH... 
Via Benzinga
Better Meme Stock: Clover Health or Senseonics Holdings?
Both could be risky propositions at current valuations. 
Via The Motley Fool
Unusual Options Activity Insight: Senseonics Holdings
On Friday, shares of Senseonics Holdings (AMEX:SENS) saw unusual options activity. After the option alert, the stock price moved up to $3.06. Sentiment: BEARISH Option Type:... 
Via Benzinga
Why Senseonics Skyrocketed 340% in the First Half of 2021
The maker of continuous glucose-monitoring systems had several positive developments. 
Via The Motley Fool
Unusual Options Activity Insight: Senseonics Holdings
Senseonics Holdings (AMEX:SENS) shares experienced unusual options activity on Thursday. The stock price moved down to $2.83 following the option alert. Sentiment: BULLISH... 
Via Benzinga
The Senseonics Price Will Start to Reflect the Key Advantage of Its Product
With markets in diabetes and wellness, Senseonics’ Eversense is an FDA-approved long-term implantable sensor that spells long-term growth for SENS stock. 
Via InvestorPlace
Understanding Senseonics Holdings's Unusual Options Activity
Shares of Senseonics Holdings (AMEX:SENS) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved down to $3.08. Sentiment:... 
Via Benzinga
Innovative Medical Technology Makes Senseonics a Long-Term Buy
Consider a niche-market investment in SENS stock as Senseonics' revenues outside the U.S. should impress even the toughest critics. 
Via InvestorPlace
Wait For a Pullback Before Taking a Position In Senseonics
SENS stock has massive potential to establish itself as a major player in the growing CGM market, but is a bit too pricey at this point. 
Via InvestorPlace
Senseonics Biggest Supporters Have Got to Be Patient
SENS stock has come a long way since the beginning of June. Can it stay on a roll? 
Via InvestorPlace
Ignore Near-Sighted Apes and Own Senseonics
Most Reddit profiteering is short-term, but SENS stock has the kind of technology to make it the next big thing for other larger populations. 
Via InvestorPlace
3 Pros and 3 Cons to Consider Before Joining the Senseonics Frenzy
Don’t jump into SENS stock before looking at the business from different angles. 
Via InvestorPlace
22 Stocks Moving in Tuesday's Pre-Market Session
Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 39% to $2.05 in pre-market trading after gaining over 5% on Monday. Marin Software Incorporated (NASDAQ: MRIN) rose 36.8% to... 
Via Benzinga
Senseonics Has Big Growth Potential From Groundbreaking Diabetes Treatment
Senseonics’ Eversense is the first long-term CGM. This advanced blood glucose monitoring tech will power SENS stock growth. 
Via InvestorPlace
24 Stocks Moving in Monday's Pre-Market Session
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceuticals disclosed positive interim... 
Via Benzinga
Cramer Shares His Thoughts On Sesen Bio, Marathon Oil, More
On CNBC's "Mad Money Lightning Round," Jim Cramer advised a viewer with a long position in Senseonics Holdings Inc (NYSE: SENS) to take some off the table. Cramer... 
Via Benzinga
Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic
On CNBC's "Mad Money Lightning Round," Jim Cramer said Senseonics Holdings Inc (NYSE: SENS) competes with DexCom, Inc. (NASDAQ: DXCM) and Abbott Laboratories (NYSE:... 
Via Benzinga
Senseonics Has Too Much Hope for Success Priced in Already
Reddit investors might be weakening, and Senseonics has to contend with a tough competitor, making SENS stock unattractive. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.